Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akiko Fuyuki

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Alimentary Pharmacology & Therapeutics|July 21, 2020
The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiotaNoboru Misawa, Takuma Higurashi, Tomohiro Takatsu, et al.
The Oncologist|February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trialTakahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
Cancers|May 14, 2022
Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled TrialAnna Ozaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Contemporary Clinical Trials Communications|July 11, 2022
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipationAtsushi Yamamoto, Takaomi Kessoku, Kosuke Tanaka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2025
Erratum: Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care SettingAtsushi Yamamoto, Takaomi Kessoku, Tomoki Ogata, et al.
BMJ Open|May 31, 2022
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipationKosuke Tanaka, Takaomi Kessoku, Atsushi Yamamoto, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Alimentary Pharmacology & Therapeutics|July 21, 2020
The benefit of elobixibat in chronic constipation is associated with faecal deoxycholic acid but not effects of altered microbiotaNoboru Misawa, Takuma Higurashi, Tomohiro Takatsu, et al.
The Oncologist|February 18, 2026
Novel antiemetic effect of naldemedine in patients initiating opioids for cancer pain: A secondary analysis of a randomized clinical trialTakahiro Higashibata, Takaomi Kessoku, Shinya Kajiura, et al.
Cancers|May 14, 2022
Effectiveness of Naldemedine Compared with Magnesium Oxide in Preventing Opioid-Induced Constipation: A Randomized Controlled TrialAnna Ozaki, Takaomi Kessoku, Kosuke Tanaka, et al.
Contemporary Clinical Trials Communications|July 11, 2022
Rationale and design of a multicenter, single-group, open-label trial aiming at investigating the effectiveness of elobixibat for loss of defecation desire in patients with chronic constipationAtsushi Yamamoto, Takaomi Kessoku, Kosuke Tanaka, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2024
Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 21, 2025
Erratum: Naldemedine for Opioid-Induced Constipation in Patients With Cancer: A Multicenter, Double-Blind, Randomized, Placebo-Controlled TrialJun Hamano, Takahiro Higashibata, Takaomi Kessoku, et al.
Diagnostics (Basel, Switzerland)|August 10, 2024
A Handheld Ultrasound Device Can Predict Constipation with Rectal Fecal Retention in a Palliative Care SettingAtsushi Yamamoto, Takaomi Kessoku, Tomoki Ogata, et al.
BMJ Open|May 31, 2022
Rationale and design of a multicentre, 12-week, randomised, double-blind, placebo-controlled, parallel-group, investigator-initiated trial to investigate the efficacy and safety of elobixibat for chronic constipationKosuke Tanaka, Takaomi Kessoku, Atsushi Yamamoto, et al.
Pageof 4